We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Explore
Renal Cell Carcinoma
Center of Excellence
In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Renal Cell Carcinoma. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.
In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Renal Cell Carcinoma. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.
You can find your saved items on your dashboard, in the "saved" tab.
You've recommended your first item
Your recommendations help us improve our content suggestions for you and other PracticeUpdate members.
You've subscribed to your first topic alert
What does that mean?
Each day, we'll check to see if new items have been published to the topics you're subscribed to, and we'll send you one email with all of the new items from that day.
We'll keep all topic alert notifications available on your dashboard for 30 days, to make sure you don't miss anything.
Lastly, whenever you have unread items in the topics you've subscribed to, the "Alerts" icon will light up in the main menu. Just click on the bell to see your five most-recent, unread notifications.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
No comments yet, be the first to start the discussion!
Fernando Vázquez-Alonso MD, PhD
Aug 07, 2014
If the ablative techniques can not be practiced because the mass is invading the renal pelvis, I think one possibility might be to practice an embolization of the mass after a renal angiography as a no invasive and palliative alternative.
We could control the hematuria and keep the renal function.
If ablation is not an option, would you consider any chemotherapeutic agents once the current symptoms have been controlled?
Fernando Vázquez-Alonso MD, PhD
Aug 16, 2014
First, I would try to practice an embolization. But, if it was not successful, I would consider target therapies as an alternative treatment, with a prior biopsy of the renal mass.
I have a little experience with target therapies for treatment of the complicated small renal masses with very good results.
Vázquez-Alonso F, Puche-Sanz I, Flores Martín JF et al. The role of the therapies in the treatment of small renal masses. Arch Esp Urol 2013 Jan-Feb 66(1):186-191.
Apr 30, 2024
Pending Moderator approval.
Are you sure you want to delete this comment? This can't be undone.
Tony
Nimeh
MD
Fernando Vázquez-Alonso MD, PhD
Aug 07, 2014
Tony Nimeh MD
Aug 14, 2014
Fernando Vázquez-Alonso MD, PhD
Aug 16, 2014
Apr 30, 2024
Pending Moderator approval.